Surgical Science Sweden AB (0AAU), the Gothenburg-based global leader in medical simulation technology, has issued formal notice of an extraordinary general meeting (EGM) to be held on 11 December 2026 at the company's premises at Drakegatan 7A in Gothenburg. The sole substantive agenda item is a board proposal to authorise the acquisition and transfer of the company's own shares. The proposed authorisation would replace an earlier resolution passed at the annual general meeting on 21 May 2026, updated to reflect new Swedish rules enabling public limited liability companies to trade own shares on MTF platforms, which come into force on 5 December 2026. Investors will be watching whether the required two-thirds supermajority threshold is met.

Key Points

  • Surgical Science Sweden AB (0AAU), traded on Nasdaq First North Growth Market, Stockholm
  • EGM called for 11 December 2026 to vote on authorising share buybacks and transfers of own shares
  • Buyback capped at one-tenth of all outstanding shares; total shares in issue stand at 51,026,236 with no treasury shares currently held
  • Shareholders should monitor whether the two-thirds supermajority of votes cast and shares represented is achieved at the EGM

Surgical Science Board Proposes Share Buyback Authority Ahead of New Swedish MTF Rules

The board of directors of Surgical Science Sweden AB is proposing that the EGM authorise the board, until the end of the next annual general meeting, to acquire own shares on one or more occasions. Under the proposal, the company may hold no more than one-tenth of all outstanding shares at any time. Acquisitions must be made on Nasdaq First North Growth Market at a price not exceeding the higher of the last independent trade price and the highest current independent purchase bid, and not below the lowest price at which an independent purchase can be made. Payment must be made in cash. The proposal has been specifically structured to comply with new Swedish legislation taking effect on 5 December 2026, which broadens the ability of public companies to transact in own shares on MTF platforms.

Transfer of Own Shares Also Included, with Flexibility for M&A Consideration

Alongside the buyback authority, the board is separately seeking authorisation to transfer own shares, either on Nasdaq First North Growth Market within the prevailing bid-offer range, or through other means including off-market transactions. Such off-market transfers may be made with or without preferential rights for shareholders, and may involve cash, set-off, or in-kind payment on market terms. The announcement states the purpose of both authorisations is to allow the board to adapt the company's capital structure to its capital needs, and notably to use acquired shares as a means of payment in the acquisition of assets or rights, suggesting a potential role in future corporate transactions.

EGM Participation Deadlines and Shareholder Record Date of 3 December 2026

Shareholders wishing to participate, either in person or by advance vote, must be recorded in the Euroclear Sweden AB share register on 3 December 2026. Notice of participation or submission of advance votes must be received by Surgical Science no later than 7 December 2026. Nominee-registered shareholders must arrange voting right registration with their nominee by the same deadline. Proxy documentation must reach the company no later than 10 December 2026. Board chairman Gisli Hennermark has been proposed to chair the meeting. The resolution on item 7 requires support from no less than two-thirds of both votes cast and shares represented at the EGM to pass.

Surgical Science Operates Globally Across Medical Simulation and Surgical Robotics Training

Surgical Science describes itself as a global leader in evidence-based medical simulation, developing virtual reality simulators and customised training solutions for surgeons and healthcare professionals. The company also partners with medical technology and robotics companies to embed simulation technology into their devices. With approximately 320 employees, the company operates from its Gothenburg headquarters alongside offices in Tel Aviv, Stockholm, Cleveland, Cardiff, Hong Kong, and Shenzhen. At the time of this notice, there were 51,026,236 shares and votes in issue, all of a single class, with no treasury shares held by the company.